The subcategory for the treatment of dyslipidemia includes 2 products for the treatment of hypercholesterolemia (Atorvanox®, Pravanox®) and 1 product for the treatment of hypertriglyceridemia (Lipemia Forte®). The product Losazide® contains a fixed combination of two active ingredients for the tretament of hypertension.
The same category also includes one oral antibiotic (Azivirus®) and one proton pump inhibitor (Lanzol®).
The same category also includes the oral solution Suomi® that contains the corticosteroid dexamethasone and the oral solution under the name Errkes®, which contains the non steroid anti-iflamatory agent ketorolac trometamol.
The category completes the product Glucoformin in the form of oral solution, which contains metformin for the treatment of diabetes.